| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director | EVP, R&D
2 companies
Leonard John M is a President And CEO at Intellia Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 27 sells.
Estimated insider holdings value: $17.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 50,985 | $71.70 | $3,655,410.40 | -1.9% | |
| Feb 3, 2021 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 177,745 | $67.26 | $11,955,394.68 | -2.2% | |
| Jan 5, 2021 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 6,239 | $55.86 | $348,510.54 | -1.3% | |
| Nov 27, 2020 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 35,000 | $38.57 | $1,350,000.00 | -3.6% | |
| Nov 25, 2020 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $36.00 | $1,800,000.00 | -9.7% | |
| Nov 16, 2020 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 20,000 | $34.00 | $680,000.00 | -4.1% | |
| Nov 4, 2020 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $26.00 | $1,300,000.00 | -9.7% | |
| Oct 7, 2020 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 5,000 | $21.83 | $109,150.00 | -1.1% | |
| Sep 1, 2020 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 5,000 | $21.83 | $109,150.00 | -1.1% | |
| Aug 6, 2020 | NTLA Intellia Therapeutics, Inc. | President And CEO | Sale+OE | 5,000 | $21.83 | $109,150.00 | -1.1% |